Management of stroke complicating cardiac catheterization with recombinant tissue-type plasminogen activator

Am J Cardiol. 1995 Oct 1;76(10):733-5. doi: 10.1016/s0002-9149(99)80212-4.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Cardiac Catheterization / adverse effects*
  • Cerebrovascular Disorders / drug therapy*
  • Cerebrovascular Disorders / etiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Plasminogen Activators / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Retrospective Studies
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Recombinant Proteins
  • Plasminogen Activators
  • Tissue Plasminogen Activator